|
US6184344B1
(en)
*
|
1995-05-04 |
2001-02-06 |
The Scripps Research Institute |
Synthesis of proteins by native chemical ligation
|
|
US6849428B1
(en)
*
|
1997-03-05 |
2005-02-01 |
New England Biolabs, Inc. |
Intein-mediated protein ligation of expressed proteins
|
|
AU745094B2
(en)
*
|
1997-06-13 |
2002-03-14 |
Gryphon Sciences |
Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution
|
|
WO1999011655A1
(en)
*
|
1997-09-04 |
1999-03-11 |
Gryphon Sciences |
Modular protein libraries and methods of preparation
|
|
AUPP589598A0
(en)
|
1998-09-14 |
1998-10-08 |
University Of Queensland, The |
Novel peptides
|
|
US7001745B1
(en)
*
|
1998-09-30 |
2006-02-21 |
New England Biolabs, Inc. |
Intein mediated peptide ligation
|
|
EP1159289A1
(en)
*
|
1999-03-11 |
2001-12-05 |
Gryphon Sciences |
Chemical synthesis and use of soluble membrane protein receptor domains
|
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
US20040014082A1
(en)
*
|
2000-08-11 |
2004-01-22 |
Invitrogen Corporation |
Highly homogeneous molecular markers for electrophoresis
|
|
JP2004506221A
(ja)
*
|
2000-08-11 |
2004-02-26 |
インヴィトロジェン コーポレーション |
高度に均一な電気泳動用分子マーカー
|
|
KR20030046389A
(ko)
*
|
2000-09-01 |
2003-06-12 |
그리폰 테라퓨틱스, 인코포레이티드 |
친핵체에 안정한 티오에스테르 발생 화합물, 제조 및 사용방법
|
|
WO2002057293A2
(en)
*
|
2001-01-22 |
2002-07-25 |
Sangamo Biosciences, Inc. |
Modified zinc finger binding proteins
|
|
US7256275B2
(en)
*
|
2001-03-09 |
2007-08-14 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
|
|
GB0113657D0
(en)
*
|
2001-06-05 |
2001-07-25 |
Geneprot Inc |
Improved native chemical ligation with three or more components
|
|
ES2411007T3
(es)
|
2001-10-10 |
2013-07-04 |
Novo Nordisk A/S |
Remodelación y glicoconjugación de péptidos
|
|
US7781488B2
(en)
*
|
2002-06-10 |
2010-08-24 |
Amylin Pharmaceuticals, Inc. |
Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation
|
|
JP2005531616A
(ja)
*
|
2002-06-29 |
2005-10-20 |
アクヴァノヴァ・ジャーマン・ソリュービリセイト・テクノロジーズ・（アーゲーテー）・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
イソフラボン濃縮物およびその製造法
|
|
US7598224B2
(en)
|
2002-08-20 |
2009-10-06 |
Biosurface Engineering Technologies, Inc. |
Dual chain synthetic heparin-binding growth factor analogs
|
|
US8227411B2
(en)
|
2002-08-20 |
2012-07-24 |
BioSurface Engineering Technologies, Incle |
FGF growth factor analogs
|
|
US7166574B2
(en)
*
|
2002-08-20 |
2007-01-23 |
Biosurface Engineering Technologies, Inc. |
Synthetic heparin-binding growth factor analogs
|
|
US20040198958A1
(en)
*
|
2002-12-11 |
2004-10-07 |
Ming-Qun Xu |
Carrier-ligand fusions and uses thereof
|
|
EP1616003A4
(en)
|
2002-12-30 |
2007-06-20 |
Gryphon Therapeutics Inc |
WATER-SOLUBLE THIOESTER AND SELENOESTER COMPOUNDS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
PL1615945T3
(pl)
|
2003-04-09 |
2012-03-30 |
Ratiopharm Gmbh |
Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
|
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
TWI353991B
(en)
*
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
PL2298347T3
(pl)
*
|
2003-05-06 |
2016-03-31 |
Bioverativ Therapeutics Inc |
Białka chimeryczne czynnika krzepnięcia do leczenia zaburzenia hemostazy
|
|
WO2004105685A2
(en)
*
|
2003-05-22 |
2004-12-09 |
Gryphon Therapeutics, Inc. |
Displaceable linker solid phase chemical ligation
|
|
US7414028B1
(en)
*
|
2004-02-04 |
2008-08-19 |
Biosurface Engineering Technologies, Inc. |
Growth factor analogs
|
|
US7671012B2
(en)
|
2004-02-10 |
2010-03-02 |
Biosurface Engineering Technologies, Inc. |
Formulations and methods for delivery of growth factor analogs
|
|
US7528105B1
(en)
|
2004-02-10 |
2009-05-05 |
Biosurface Engineering Technologies |
Heterodimeric chain synthetic heparin-binding growth factor analogs
|
|
US20060024347A1
(en)
*
|
2004-02-10 |
2006-02-02 |
Biosurface Engineering Technologies, Inc. |
Bioactive peptide coatings
|
|
US20080227696A1
(en)
|
2005-02-22 |
2008-09-18 |
Biosurface Engineering Technologies, Inc. |
Single branch heparin-binding growth factor analogs
|
|
JP4895826B2
(ja)
*
|
2004-02-20 |
2012-03-14 |
バイオサーフェス エンジニアリング テクノロジーズ，インク． |
骨形成蛋白−２の正のモジュレーター
|
|
TWI351284B
(en)
|
2004-04-09 |
2011-11-01 |
Chugai Pharmaceutical Co Ltd |
Novel water-soluble prodrugs
|
|
US7872096B2
(en)
*
|
2004-05-24 |
2011-01-18 |
Rigel Pharmaceuticals, Inc. |
Methods for cyclizing synthetic polymers
|
|
CN102343084A
(zh)
|
2005-03-31 |
2012-02-08 |
安米林药品公司 |
用于治疗精神病和精神障碍的胰淀素和胰淀素激动剂
|
|
TW200744603A
(en)
|
2005-08-22 |
2007-12-16 |
Chugai Pharmaceutical Co Ltd |
Novel anticancer concomitant drug
|
|
WO2007100358A2
(en)
*
|
2005-10-07 |
2007-09-07 |
University Of Chicago |
Convergent synthesis of proteins by kinetically controlled ligation
|
|
US20090118271A1
(en)
*
|
2005-10-19 |
2009-05-07 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug
|
|
US7820172B1
(en)
|
2006-06-01 |
2010-10-26 |
Biosurface Engineering Technologies, Inc. |
Laminin-derived multi-domain peptides
|
|
JP2009541358A
(ja)
|
2006-06-22 |
2009-11-26 |
バイオサーフェス エンジニアリング テクノロジーズ，インク． |
骨形成を強化するためにｂｍｐ−２増幅因子／共活性化因子を送達するための組成物および方法
|
|
US8309522B2
(en)
|
2007-02-05 |
2012-11-13 |
Amylin Pharmaceuticals, Llc |
Neuromedin and FN-38 peptides for treating psychiatric diseases
|
|
US8404804B2
(en)
*
|
2007-08-28 |
2013-03-26 |
Ipsen Pharma S.A.S. |
Methods and intermediates for chemical synthesis of polypeptides and proteins
|
|
EP2536287A4
(en)
*
|
2010-02-18 |
2015-10-07 |
Advanced Proteome Therapeutics Inc |
SPECIFIC SITE SIZE OF PROTEINS USING CHEMICAL MODIFICATION TO PROMOTE PROTEIN CONJUGATE FORMATION, PROTEIN DIMER FORMATION, AND AGRAFTED PEPTIDES
|
|
CA2812951A1
(en)
|
2010-09-28 |
2012-04-19 |
Amylin Pharmaceuticals, Llc |
Engineered polypeptides having enhanced duration of action
|
|
PT2621515T
(pt)
|
2010-09-28 |
2017-07-12 |
Aegerion Pharmaceuticals Inc |
Polipéptido quimérico de leptina de foca-ser humano com solubilidade aumentada
|
|
CN103957926B
(zh)
|
2011-07-08 |
2018-07-03 |
安米林药品有限责任公司 |
具有增强的作用持续时间和降低的免疫原性的工程改造的多肽
|
|
JP6006309B2
(ja)
|
2011-07-08 |
2016-10-12 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
|
|
FR2981352B1
(fr)
*
|
2011-10-17 |
2015-07-03 |
Centre Nat Rech Scient |
Procede de synthese de proteines
|
|
CA2873112A1
(en)
|
2012-05-11 |
2013-11-14 |
Alexander Krantz |
Site-specific labeling and targeted delivery of proteins for the treatment of cancer
|
|
WO2013177231A1
(en)
|
2012-05-21 |
2013-11-28 |
Massachusetts Institute Of Technology |
Translocation of non-natural chemical entities through anthrax protective antigen pore
|
|
WO2014144549A1
(en)
|
2013-03-15 |
2014-09-18 |
Biogen Idec Ma Inc. |
Factor ix polypeptide formulations
|
|
US11273176B2
(en)
|
2016-03-02 |
2022-03-15 |
The Brigham And Women's Hospital, Inc. |
Use of PLA2G5-deficient suppressive macrophages in suppression of inflammation
|
|
CN110382516B
(zh)
*
|
2017-03-02 |
2022-11-08 |
株式会社糖锁工学研究所 |
氨基酸聚合物的制备方法
|
|
WO2020070587A1
(en)
|
2018-10-01 |
2020-04-09 |
Université De Genève |
Methods for producing a plurality of polypeptide variants suitable for biological analysis
|
|
WO2020110330A1
(ja)
*
|
2018-11-30 |
2020-06-04 |
株式会社糖鎖工学研究所 |
ペプチドチオエステル、ペプチドの新規製造方法
|
|
WO2021072306A1
(en)
|
2019-10-10 |
2021-04-15 |
1859, Inc. |
Methods and systems for microfluidic screening
|
|
WO2021077317A1
(zh)
*
|
2019-10-23 |
2021-04-29 |
烟台迈百瑞国际生物医药股份有限公司 |
一种寡肽连接子中间体及其制备方法
|
|
WO2022266467A2
(en)
|
2021-06-17 |
2022-12-22 |
Dana-Farber Cancer Institute, Inc. |
Recombinant histone polypeptide and uses thereof
|
|
WO2024146707A1
(en)
|
2023-01-06 |
2024-07-11 |
Université De Genève |
Variant ligand conjugates for payload delivery
|